$EXPO
EXPONENT INC

2015 Q3 Form 10-Q Financial Statement

#000114420415047333 Filed on August 07, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $79.86M $76.57M
YoY Change 4.3% 1.79%
Cost Of Revenue $4.600M $4.200M
YoY Change 9.52% -17.65%
Gross Profit $75.30M $72.30M
YoY Change 4.15% 3.14%
Gross Profit Margin 94.29% 94.42%
Selling, General & Admin $49.90M $49.80M
YoY Change 0.2% 2.68%
% of Gross Profit 66.27% 68.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.300M $1.300M
YoY Change 0.0% 0.0%
% of Gross Profit 1.73% 1.8%
Operating Expenses $61.16M $60.49M
YoY Change 1.11% 0.7%
Operating Profit $18.71M $16.08M
YoY Change 16.3% 6.09%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $587.0K $2.314M
YoY Change -74.63% -1.74%
Pretax Income $19.29M $18.40M
YoY Change 4.86% 5.04%
Income Tax $7.595M $7.134M
% Of Pretax Income 39.37% 38.78%
Net Earnings $11.70M $11.26M
YoY Change 3.84% 1.53%
Net Earnings / Revenue 14.65% 14.71%
Basic Earnings Per Share $0.44 $0.42
Diluted Earnings Per Share $0.43 $0.41
COMMON SHARES
Basic Shares Outstanding 26.71M shares 27.04M shares
Diluted Shares Outstanding 27.37M shares 27.75M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.9M $144.5M
YoY Change 3.74% 7.04%
Cash & Equivalents $131.9M $112.9M
Short-Term Investments $17.90M $31.60M
Other Short-Term Assets $25.70M $24.90M
YoY Change 3.21% 39.89%
Inventory
Prepaid Expenses
Receivables $93.50M $85.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $269.1M $255.2M
YoY Change 5.44% 8.6%
LONG-TERM ASSETS
Property, Plant & Equipment $27.50M $28.83M
YoY Change -4.62% 1.52%
Goodwill $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $62.80M $1.110M
YoY Change 5557.66% -97.89%
Total Long-Term Assets $99.00M $95.90M
YoY Change 3.23% 7.15%
TOTAL ASSETS
Total Short-Term Assets $269.1M $255.2M
Total Long-Term Assets $99.00M $95.90M
Total Assets $368.1M $351.1M
YoY Change 4.84% 8.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.700M $10.00M
YoY Change -3.0% 96.08%
Accrued Expenses $48.90M $47.60M
YoY Change 2.73% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.50M $64.51M
YoY Change -0.02% 9.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $44.00M $1.884M
YoY Change 2235.46% -94.6%
Total Long-Term Liabilities $44.00M $1.884M
YoY Change 2235.46% -94.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.50M $64.51M
Total Long-Term Liabilities $44.00M $1.884M
Total Liabilities $108.5M $105.2M
YoY Change 3.14% 12.15%
SHAREHOLDERS EQUITY
Retained Earnings $255.7M $233.4M
YoY Change 9.53% 6.35%
Common Stock $157.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $170.2M $145.6M
YoY Change 16.91%
Treasury Stock Shares 6.931M shares 3.339M shares
Shareholders Equity $259.6M $245.9M
YoY Change
Total Liabilities & Shareholders Equity $368.1M $351.1M
YoY Change 4.83% 8.2%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $11.70M $11.26M
YoY Change 3.84% 1.53%
Depreciation, Depletion And Amortization $1.300M $1.300M
YoY Change 0.0% 0.0%
Cash From Operating Activities $13.10M $16.80M
YoY Change -22.02% -3.45%
INVESTING ACTIVITIES
Capital Expenditures $1.087M $1.061M
YoY Change 2.45% 18.95%
Acquisitions
YoY Change
Other Investing Activities $3.300M $0.00
YoY Change -100.0%
Cash From Investing Activities $2.100M -$1.100M
YoY Change -290.91% -85.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.100M -9.000M
YoY Change -21.11% 73.08%
NET CHANGE
Cash From Operating Activities 13.10M 16.80M
Cash From Investing Activities 2.100M -1.100M
Cash From Financing Activities -7.100M -9.000M
Net Change In Cash 8.100M 6.700M
YoY Change 20.9% 52.27%
FREE CASH FLOW
Cash From Operating Activities $13.10M $16.80M
Capital Expenditures $1.087M $1.061M
Free Cash Flow $12.01M $15.74M
YoY Change -23.67% -4.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7284000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6267000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7004000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14383000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-17178000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-20600000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-46000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
674000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
14000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-918000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
255689000 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
170249000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
259593000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
368074000 USD
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
75272000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
72331000 USD
CY2015Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
4592000 USD
CY2014Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
4243000 USD
CY2015Q3 us-gaap Revenues
Revenues
79864000 USD
CY2014Q3 us-gaap Revenues
Revenues
76574000 USD
CY2015Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
45777000 USD
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46049000 USD
CY2015Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6703000 USD
CY2014Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6450000 USD
CY2015Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4592000 USD
CY2014Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4243000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4087000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3748000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
18705000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16084000 USD
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
34000 USD
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
40000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
553000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2274000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19292000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18398000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7595000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7134000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
11697000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10053000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122948000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112895000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
11264000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26714000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27040000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27368000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27746000 shares
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
61159000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
60490000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
587000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2314000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2705000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2633000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-395000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-443000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-7000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-132000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
509000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
828000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7902000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7875000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1071000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3896000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4486000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5090000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7684000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9643000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1195000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3348000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5117000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6504000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9446000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6027000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2339000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
165000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14820000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10730000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1714000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1976000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
10555000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
2186000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4841000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-857000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4486000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5090000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
631000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1540000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
8007000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
6580000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2437000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
22000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6008000 USD
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
162833 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7004000 USD
CY2014Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2015Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
197988 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14383000 USD
CY2015Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28074000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
6050000 USD
CY2014Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1061000 USD
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1324000 USD
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1311000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
9346000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8509000 USD
us-gaap Revenues
Revenues
152536000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
96892000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
94907000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13213000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12767000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
8744000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
7238000 USD
CY2015Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
69701000 USD
CY2015Q3 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
46884000 USD
CY2015Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
46884000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45478000 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114239000 USD
CY2015Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
45394000 USD
CY2015Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
45394000 USD
CY2015Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
13414000 USD
CY2015Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
4526000 USD
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
17940000 USD
CY2015Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
13411000 USD
CY2015Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
4524000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1257000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-904000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3485000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3386000 USD
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6931000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7111000 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
151413000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
145298000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
8744000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
7238000 USD
us-gaap Revenues
Revenues
160157000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7575000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7446000 USD
us-gaap Operating Expenses
OperatingExpenses
126424000 USD
us-gaap Operating Expenses
OperatingExpenses
122358000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
33733000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
30178000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
68000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
84000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2562000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3501000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2630000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3585000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36363000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33763000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14333000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13345000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.250
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1067000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26668000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27056000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27386000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27838000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.300
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
317000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
369000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11852000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11589000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21677000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20809000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2015Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q3 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2014Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
149867000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
226000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
767000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.150
CY2015Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.150
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3858000 USD
CY2015Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3887000 USD
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2014Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2014Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2014Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3270000 USD
CY2014Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3216000 USD
CY2015 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13010000 USD
CY2015Q3 expo Common Stock Dividends Per Share Declared Subsequent Event
CommonStockDividendsPerShareDeclaredSubsequentEvent
0.15
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2015Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
two-for-one stock split
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7745000 USD
CY2015Q3 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
149862000 USD
CY2015Q3 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2015Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015Q3 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2015Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q3 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
3000 USD
CY2015Q3 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
8000 USD

Files In Submission

Name View Source Status
0001144204-15-047333-index-headers.html Edgar Link pending
0001144204-15-047333-index.html Edgar Link pending
0001144204-15-047333.txt Edgar Link pending
0001144204-15-047333-xbrl.zip Edgar Link pending
expo-20150703.xml Edgar Link completed
expo-20150703.xsd Edgar Link pending
expo-20150703_cal.xml Edgar Link unprocessable
expo-20150703_def.xml Edgar Link unprocessable
expo-20150703_lab.xml Edgar Link unprocessable
expo-20150703_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v416257_10q.htm Edgar Link pending
v416257_ex31-1.htm Edgar Link pending
v416257_ex31-2.htm Edgar Link pending
v416257_ex32-1.htm Edgar Link pending
v416257_ex32-2.htm Edgar Link pending